Matthew Fell

1. MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
   2015/09/26 by Matthew Fell, Matthew J. Fell, Christian Mirescu +20 · 8 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Parkinson's Disease Mechanisms and Treatments #Plant Gene Expression Analysis #Alzheimer's disease research and treatments